Active vs. latent tuberculosis: what’s the difference?
Tuberculosis (TB) can exist in two forms: latent TB infection (LTBI) and active TB. The medical community now commonly refers to these two states as TB infection (TBI) and TB disease. While both latent and active TB are caused by the same bacteria (Mycobacterium tuberculosis), they differ significantly in symptoms, infectiousness and treatment approach. Understanding the differences is essential for timely diagnosis and prevention.
Active vs. latent TB: key differences
The main difference between active TB and latent TB is that people with active TB have symptoms of disease and can spread TB infection to others. People with latent TB, on the other hand, are infected with TB bacteria that is inactive or dormant. Although they do not show any symptoms, they are at risk of progressing to active TB disease in the future.
What is active tuberculosis (TB disease)?
Active tuberculosis is a condition in which TB bacteria are actively multiplying and causing illness. Active TB typically affects the lungs (pulmonary tuberculosis), but can also spread to other organs such as the lymph nodes, brain or kidneys (extrapulmonary tuberculosis). Common symptoms of active TB include persistent cough, fever, night sweats and weight loss. Prompt diagnosis and multidrug treatment are critical to cure the disease and prevent spread. If left untreated, active TB has a high rate of mortality (death).
What is latent tuberculosis (TB infection)?
Latent TB infection occurs when a person is infected with TB bacteria, but the immune system keeps it under control. People with latent TB have no symptoms and are not contagious. However, the bacteria remain alive in the body and can reactivate under certain conditions. Detecting and treating latent TB is a key strategy in global TB control and disease prevention.
Comparing active and latent TB (TB disease vs. TB infection)
| Feature | Latent tuberculosis (TB infection) | Latent Tuberculosis |
| Bacterial state | Dormant (inactive) | Active and multiplying |
| Symptoms | None | Present (e.g., cough, fever, night sweats, weight loss) |
| Contagious | None | Yes, can spread to others |
| Feature | Latent Tuberculosis (TB infection) | Active Tuberculosis (TB disease) |
| Risk to health | No immediate illness but risk of future activation |
Causes illness, and can be severe if untreatedt |
| Diagnosis | Blood test (e.g., QuantiFERON) or skin test |
Chest X-ray, sputum tests, microbiological confirmation |
| Treatment goal | Prevent progression to active TB | TB Cure disease and stop transmission |
| Treatment duration | Shorter preventive therapy (varies by regimen) |
Typically 6 months or longer (multi-drug therapy) |
| Public health impact | Reservoir for future TB case | Immediate transmission risk |
When can latent TB become active?
Latent TB can become active when the immune system is weakened and can no longer contain the bacteria. This may occur due to factors such as HIV infection, immunosuppressive therapies, diabetes or aging. The highest risk of progression is typically within the first few years after initial infection. Identifying individuals at risk of progression allows for preventive treatment before active disease develops.
Symptoms of active TB
Active TB commonly presents with a persistent cough lasting more than two to three weeks, sometimes with blood-tinged sputum. Other symptoms include fever, night sweats, fatigue, chest pain and unexplained weight loss. These symptoms can range from mild to severe depending on disease progression. Because they overlap with other respiratory conditions, accurate testing is essential for diagnosis.
How active TB is treated?
Active TB is treated with a combination of antibiotics taken over several months, typically at least six months. This multi-drug approach helps eliminate the bacteria and prevents the development of drug resistance. Adherence to the full treatment regimen is critical for successful outcomes. Public health monitoring is often involved to ensure treatment completion and reduce transmission.
Why does latent TB have no symptoms?
In latent TB infection, the immune system effectively contains the bacteria, preventing them from multiplying and causing damage. As a result, there is no inflammation or tissue destruction that would lead to symptoms. The bacteria remain dormant but viable within the body. This silent state is why diagnostic testing is necessary to detect latent TB infection.
Latent TB testing – QuantiFERON
Testing for latent TB is essential because individuals do not show symptoms. Blood-based interferon-gamma release assays (IGRAs), such as QuantiFERON-TB Gold Plus, offer a modern alternative to traditional skin testing. These tests help detect immune responses to TB infection with high specificity, including in BCG-vaccinated populations. Accurate detection supports early intervention and helps reduce progression to active TB.
How latent TB is treated?
Latent TB treatment usually involves one or more antibiotics taken over a shorter course than active TB treatment, depending on the regimen. Treatment is especially recommended for individuals at higher risk of progression to active disease. Early intervention helps reduce the overall burden of TB in the community.
Active vs latent TB: key takeaways
Active TB is symptomatic and contagious, while latent TB is asymptomatic and non-infectious. Both forms originate from the same bacteria but require different clinical approaches. Early and accurate testing is crucial to identify latent infection and prevent disease progression. Addressing both forms is essential for effective TB control and improved patient outcomes.